De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review

De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review

Saved in:

Bibliographic Details
Main Authors:	Hanxu Guo, Chengqi Jin, Li Ding, Jun Xie, Jing Xu, Ruiliang Wang, Hong Wang, Changcheng Guo, Jiansheng Zhang, Bo Peng, Xudong Yao, Jing Yuan, Bin Yang, Sihan Zhou
Format:	Article
Language:	English
Published:	Wolters Kluwer 2025-01-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000003311
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel
by: Filippo Francini, et al.
Published: (2011-01-01)

Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells
by: Eleftheria Tsakalozou, et al.
Published: (2012-01-01)

Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
by: Osama Diab, et al.
Published: (2019-01-01)

Sequential Docetaxel in ≥7 Cycles Followed by Cabazitaxel Improves Oncological Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
by: Seiichi Kato, et al.
Published: (2021-01-01)

A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate Cancer
by: Aseem Samar, et al.
Published: (2020-01-01)

Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
by: Bin Han, et al.
Published: (2012-01-01)

HTA and Reimbursement Status of Metastatic Hormone‑Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review
by: Goran Bencina, et al.
Published: (2023-06-01)

Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel
by: Keith L. Davis, et al.
Published: (2015-01-01)

ABA enhances the apoptotic effect of docetaxel in the multidrug-resistant DU145 prostate cancer cell line
by: Şumnulu Deniz, et al.
Published: (2024-01-01)

Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer
by: Furnback W, et al.
Published: (2025-02-01)

Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with castration-resistant prostate cancer treated with docetaxel-based chemotherapy: a meta-analysis
by: Ying Zhang, et al.
Published: (2025-01-01)

Metastatic Breast Carcinoma to the Prostate Gland
by: Meghan E. Kapp, et al.
Published: (2016-01-01)

Stauffer’s Syndrome in Patient with Metastatic Prostate Cancer
by: Andris Romašovs, et al.
Published: (2019-01-01)

Triplet Delivery following Unilateral Twin Salpingocyesis
by: Johnson O. Komolafe, et al.
Published: (2015-01-01)

Role of 18F-PSMA-1007 PET/CT-derived quantitative volumetric tumor parameters in cytoreductive radical prostatectomy selection for patients with low-volume metastatic hormone-sensitive prostate cancer: a retrospective study
by: Junjie Fan, et al.
Published: (2025-02-01)

Metastatic gastric adenocarcinoma in prostate: A case report
by: Naru Shimizu, et al.
Published: (2025-03-01)

New Primary Malignancy Masquerading as Metastatic Prostate Adenocarcinoma
by: Ellen A. Szwed, et al.
Published: (2015-01-01)

Spontaneous Ovarian Hyperstimulation Syndrome in a Triplet Pregnancy
by: Nisha Rani Agrawal, et al.
Published: (2012-01-01)

The perfect molecule for hormonal contraception: Estetrol benefits. A review
by: Elena A. Gorbunova, et al.
Published: (2024-12-01)

Biomarkers in metastatic castration-resistant prostate cancer for efficiency of immune checkpoint inhibitors
by: Zixi Wu, et al.
Published: (2025-12-01)

Inverse Relationship Between Leydig Cell Density and Metastatic Potential of Prostatic Adenocarcinoma
by: W. John Wang, et al.
Published: (1999-01-01)

New Horizons In The Treatment Of Metastatic Castrate Resistant Prostate Cancer
by: Zein El Amir
Published: (2023-06-01)

Pulmonary Tumor Thrombotic Microangiopathy from Metastatic Prostate Carcinoma
by: Dhruv Nayyar, et al.
Published: (2015-01-01)

An Unusual Case of Acute Appendicitis due to Metastatic Prostatic Adenocarcinoma
by: Numbereye Numbere, et al.
Published: (2020-01-01)

Gate modulation of the hole singlet-triplet qubit frequency in germanium
by: John Rooney, et al.
Published: (2025-01-01)

Human parathyroid hormone fragment stimulates the de novo synthesis of prostaglandin endoperoxide synthase in chick calvaria
by: Chin-Yuh Yang, et al.
Published: (1993-01-01)

De Novo Transcriptome Assembly and Differential Gene Expression Profiling of Three Capra hircus Skin Types during Anagen of the Hair Growth Cycle
by: Teng Xu, et al.
Published: (2013-01-01)

The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton
by: Emma Roberts, et al.
Published: (2013-01-01)

RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER
by: A. A. Kostin, et al.
Published: (2017-12-01)

Morphometric parameters of pelvic lymph nodes in experimental metastatic prostate cancer
by: V. V. Astashov, et al.
Published: (2023-06-01)

The Prognostic Importance of Prostate-Specific Antigen in Monitoring Patients Undergoing Maximum Androgen Blockage for Metastatic Prostate Cancer
by: Ahmet Kiper, et al.
Published: (2005-01-01)

Ground Settlements due to Construction of Triplet Tunnels with Different Construction Arrangements
by: Ahsan Naseem, et al.
Published: (2019-01-01)

Ultrafast Charge and Triplet State Formation in Diketopyrrolopyrrole Low Band Gap Polymer/Fullerene Blends: Influence of Nanoscale Morphology of Organic Photovoltaic Materials on Charge Recombination to the Triplet State
by: René M. Williams, et al.
Published: (2017-01-01)

AGD1/USP10/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate cancer
by: Hong Wang, et al.
Published: (2025-01-01)

Correlation of international prostatic symptom score with prostate volume
by: Iffat Raza, et al.
Published: (2023-01-01)

The Kinetics of Joined Action of Triplet-Triplet Annihilation and First-Order Decay of Molecules in T1 State in the Case of Nondominant First-Order Process: The Kinetic Model in the Case of Spatially Periodic Excitation
by: Paweł Borowicz, et al.
Published: (2013-01-01)

Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
by: Joelle El-Amm, et al.
Published: (2013-01-01)

Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
by: Hamid Reza Mirzaei, et al.
Published: (2013-01-01)

Conditional similarity triplets enable covariate-informed representations of single-cell data
by: Chi-Jane Chen, et al.
Published: (2025-02-01)

Neonatal Outcome from Triplet Interval Delayed Delivery: A Case Report
by: Monika Lachowska, et al.
Published: (2013-01-01)